Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2003 Jun 24;10013:7476-9. doi: 10.1073/pnas.1330865100.
Show Gene links
Show Anatomy links
Validation of the hexose transporter of Plasmodium falciparum as a novel drug target.
Joet T
,
Eckstein-Ludwig U
,
Morin C
,
Krishna S
.
???displayArticle.abstract???
Chemotherapy of malaria parasites is limited by established drug resistance and lack of novel targets. Intraerythrocytic stages of Plasmodium falciparum are wholly dependent on host glucose for energy. Glucose uptake is mediated by a parasite-encoded facilitative hexose transporter (PfHT). We report that O-3 hexose derivatives inhibit uptake of glucose and fructose by PfHT when expressed in Xenopus oocytes. Selectivity of these derivatives for PfHT is confirmed by lack of inhibition of hexose transport by the major mammalian glucose and fructose transporters (Gluts) 1 and 5. A long chain O-3 hexose derivative is the most effective inhibitor of PfHT and also kills P. falciparum when it is cultured in medium containing either glucose or fructose as a carbon source. To extend our observations to the second most important human malarial pathogen, we have cloned and expressed the Plasmodium vivax orthologue of PfHT, and demonstrate inhibition of glucose uptake by the long chain O-3 hexose derivative. Furthermore, multiplication of Plasmodium berghei in a mouse model is significantly reduced by the O-3 derivative. Our robust expression system conclusively validates PfHT as a novel drug target and is an important step in the development of novel antimalarials directed against membrane transport proteins.
BOURNE,
The methyl ethers of D-glucose.
1950, Pubmed
BOURNE,
The methyl ethers of D-glucose.
1950,
Pubmed
Bignan,
Synthesis of 3-O-(iodoethyl)-D-glucose, a stable iodo derivative of D-glucose for medical imaging.
1993,
Pubmed
Corpe,
Cloning and functional characterization of the mouse fructose transporter, GLUT5.
2002,
Pubmed
,
Xenbase
Gardner,
Genome sequence of the human malaria parasite Plasmodium falciparum.
2002,
Pubmed
Ikekawa,
Studies on synthesis of 3-O-alkyl-D-glucose and 3-O-alkyl-D-allose derivatives and their biological activities.
1987,
Pubmed
Joët,
Comparative characterization of hexose transporters of Plasmodium knowlesi, Plasmodium yoelii and Toxoplasma gondii highlights functional differences within the apicomplexan family.
2002,
Pubmed
,
Xenbase
Kirk,
Membrane transport in the malaria-infected erythrocyte.
2001,
Pubmed
Krishna,
Transport processes in Plasmodium falciparum-infected erythrocytes: potential as new drug targets.
2002,
Pubmed
,
Xenbase
Krishna,
Hexose transport in asexual stages of Plasmodium falciparum and kinetoplastidae.
2000,
Pubmed
Manning,
Mutational analysis of the hexose transporter of Plasmodium falciparum and development of a three-dimensional model.
2002,
Pubmed
,
Xenbase
Ridley,
Medical need, scientific opportunity and the drive for antimalarial drugs.
2002,
Pubmed
Thaithong,
Resistance of ten Thai isolates of Plasmodium falciparum to chloroquine and pyrimethamine by in vitro tests.
1981,
Pubmed
Woodrow,
Hexose permeation pathways in Plasmodium falciparum-infected erythrocytes.
2000,
Pubmed
,
Xenbase
Woodrow,
Intraerythrocytic Plasmodium falciparum expresses a high affinity facilitative hexose transporter.
1999,
Pubmed
,
Xenbase
Zeller,
Synthesis and mass spectra of 4-O-acetyl-1,5-anhydro-2,3,6-tri-O-ethyl-D-glucitol and the positional isomers of 4-O-acetyl-1,5-anhydro-di-O-ethyl-O- methyl-D-glucitol and 4-O-acetyl-1,5-anhydro-O-ethyl-di-O-methyl-D-glucitol.
1988,
Pubmed
ter Kuile,
Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria.
1993,
Pubmed